Senior insider sale
Sr. V.P., Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.62M
56.40K shares
MARTIN TAMI TILLOTSON plans to sell 56.40K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $1.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of options under a registered plan
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/29/2024 | Exercise of options under a registered plan Cash | 5K | — |
| Total | 5K | ||
Completed
Units to sell
5.75K
Market value
$176.0K
Units to sell
7K
Market value
$214.3K
Units to sell
5K
Market value
$149.4K
Units to sell
6.25K
Market value
$181.5K
Units to sell
13.90K
Market value
$389.2K
Units to sell
3.50K
Market value
$92.7K
Units to sell
5K
Market value
$130.9K
Units to sell
5K
Market value
$134.2K
Planned — Approximate Date
Units to sell
5K
Market value
$153.8K
Units
56.40K
Value
$1.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/24/2024 | 5.75K | $176.0K | — | Completed |
7/22/2024 | 7K | $214.3K | — | Completed |
7/19/2024 | 5K | $149.4K | — | Completed |
7/15/2024 | 6.25K | $181.5K | — | Completed |
7/11/2024 | 13.90K | $389.2K | — | Completed |
7/9/2024 | 3.50K | $92.7K | — | Completed |
7/8/2024 | 5K | $130.9K | — | Completed |
6/25/2024 | 5K | $134.2K | — | Completed |
| Planned — Approximate Date | ||||
7/29/2024 | 5K | $153.8K | NASDAQ | Planned |
| Total | 56.40K | $1.62M | ||